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Abstract
Background: Proteinuria is a common clinical presentation, the diagnostic workup for which involves many non-
invasive and invasive investigations. We report on two siblings that highlight the clinically relevant functional role of
cubulin for albumin resorption in the proximal tubule and supports the use of genomic sequencing early in the
diagnostic work up of patients who present with proteinuria.
Case presentation: An 8-year-old boy was referred with an incidental finding of proteinuria. All preliminary
investigations were unremarkable. Further assessment revealed consanguineous family history and a brother with
isolated proteinuria. Renal biopsy demonstrated normal light microscopy and global glomerular basement membrane
thinning on electron microscopy. Chromosomal microarray revealed long continuous stretches of homozygosity
(LCSH) representing ~ 4.5% of the genome. Shared regions of LCSH between the brothers were identified and their
further research genomic analysis implicated a homozygous stop-gain variant in CUBN (10p12.31).
Conclusions: CUBN mutations have been implicated as a hereditary cause of megaloblastic anaemia and variable
proteinuria. This is the second reported family with isolated proteinuria due to biallelic CUBN variants in the absence of
megaloblastic anaemia, demonstrating the ability of genomic testing to identify genetic causes of nephropathy within
expanding associated phenotypic spectra. Genomic sequencing, undertaken earlier in the diagnostic trajectory, may
reduce the need for invasive investigations and the time to definitive diagnosis for patients and families.
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Background
Proteinuria is a common clinical presentation that is as-
sociated with poor renal outcomes, especially when se-
vere [1]. Historically, the diagnostic workup of patients
with isolated proteinuria involved urinalysis, imaging
and blood sampling before potentially proceeding to
histological diagnosis via renal biopsy. Many nephropa-
thies can cause proteinuria, which gives rise to
indistinguishable phenocopies, even when histological
examination is performed. This is particularly the case
in children. Recently, advances in technology has re-
sulted in the reduced cost and increased availability of
genomic sequencing for establishing a clinical diagnosis
[2]. In addition, preliminary studies have demonstrated
genomics to be useful as a diagnostic test in selected pa-
tients with kidney disease [3]. Although current treat-
ment strategies target glomerular filtration of albumin,
more recent data suggests there are also clinically rele-
vant functions of the proximal tubule in albumin
homeostasis. We present the cases of two siblings which
supports the clinically relevant functional role of cubulin
for albumin resorption in the proximal tubule and
suggest that genomic sequencing be undertaken early in
the diagnostic work up of patients presenting with
proteinuria.
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Case presentation
An 8-year-old boy was referred to the paediatric neph-
rology service with an incidental finding of persistent
proteinuria during investigation for abdominal pain. He
had no hematuria or glycosuria. He had normal serum
albumin (42 g/L). Haematological, biochemical and im-
munological parameters were unremarkable. Specifically,
C3, C4, ANCA and anti-GBM were negative and ANA
was moderately positive (1:320). Renal function was
normal (serum creatinine 0.52 mg/dL). Urinary albumin
creatinine ratio was raised at 51.4 mg/mmol (normal <
3.5/mg/mmol) and protein creatinine ratio 92 mg/mmol
(normal< 20mg/mmol). Urine electrophoresis was 1.47
g/L with non-selective proteinuria pattern detected (nor-
mal< 0.10 g/L). Assessment for glycosuria, urinary light
chains and urinary amino acids was negative. Urinary
electrolytes were normal, and haematuria was absent on
serial testing. Renal ultrasound, ophthalmology and
audiology assessment did not demonstrate any abnormal
findings. Renal biopsy demonstrated normal light mi-
croscopy and there was no evidence of immune complex
mediated disease or other pathology. Podocyte foot pro-
cesses were generally well preserved on electron micros-
copy, however there was global uniform thinning of the
glomerular basement membrane (Fig. 1).
Family history assessment revealed that his parents
were first cousins, of Middle Eastern descent, with no
known family history of renal disease or other comorbid-
ity. Further investigation of the family revealed isolated
proteinuria (urinary albumin creatinine 55.6 mg/mmol,
protein creatinine 89.4 mg/mmol) in his 4-year old
brother but not in either parent. His brother’s haemato-
logical parameters were unremarkable and remaining
urinary investigations were within normal range apart
from an elevated urinary protein electrophoresis (1.32 g/
L). Chromosomal microarray in the older sibling
revealed long continuous stretches of homozygosity
(LCSH) representing ~ 4.5% of the genome, consistent
with parental consanguinity. Shared regions of LCSH be-
tween the brothers were interrogated using the Genomic
Oligoarray and single nucleotide polymorphism (SNP)
evaluation tool© [4]. Whole genome sequencing was per-
formed on both affected individuals after informed consent
(HREC/15/QRCH/126). Segregating variants were examined
in the previously identified areas of LCSH and in all gen-
omic areas in a curated list of glomerular disease associated
genes [5]. This revealed both brothers had a homozygous
stop-gain variant NM_001081.3:c.4689_4690delTAinsAT;
p.(Cys1563Ter) in exon 31 of the gene CUBN. Biallelic
variants in CUBN have previously been associated with
Imerslund-Grasbeck Syndrome (Megaloblastic anemia-1,
Finnish type (MIM: 261100)) and one reported case of iso-
lated proteinuria [6–8]. The c.4689_4690delTAinsAT vari-
ant is present in 47 individuals in the gnomAD database
including a single homozygous individual. The variant is
most common in the “South Asian” gnomAD population
with an allele frequency of 0.0012. Based on this evidence
the variant was classified as pathogenic according to ACMG
criteria (PVS1, PM2 and PP1) [9]. At four years of follow-
up, the patient and his younger brother remain well with
isolated proteinuria. Given the genomic diagnosis, biopsy of
the younger brother was not required. Both were com-
menced on renin-angiotensin-aldosterone system (RAAS)
blockade with a mild reduction in proteinuria (urine protein:
creatinine 74.6mg/mmol in the elder brother and 73.8mg/
mmol in the younger brother). Haematological parameters
remained normal in both siblings.
Discussion and conclusions
The causes of isolated proteinuria can be divided into
glomerular, tubular and overflow proteinuria. Glomeru-
lar proteinuria occurs in nephrotic syndrome due to
increased permeability of the glomerular capillary wall,
resulting in the abnormal passage of proteins from the
glomerulus [10]. Tubular proteinuria which occurred in
this case, is typically due to increased excretion of low
molecular weight proteins, such as beta-2 microglobulin,
retinol binding protein and vitamin D-binding protein
(DBP) due to abnormalities in proximal tubular
reabsorption of these proteins [11]. A classic example is
Fanconi syndrome, which has acquired and inherited
associations. Lastly, overflow proteinuria is due to over-
production of an individual protein, for example in mul-
tiple myeloma. We infer that the CUBN mutation in our
patients may have led to predominant albuminuria due
to a deficiency in tubular reabsorption of albumin.
The role of megalin and cubulin in proximal protein-
uria has been postulated in several studies, with the most
recent study demonstrating that while megalin/cubulin
mouse knockouts result in blocked proximal tubular
Fig. 1 Electron Microscopy demonstrating global uniform thinning
of glomerular basement membrane
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albumin uptake, this did not affect plasma albumin levels
in nephrotic mice [12] . This suggests there is not a sig-
nificant contribution of the megalin/cubulin pathway for
albumin homeostasis. A prior study nevertheless re-
ported a 20% decrease in plasma albumin levels in cubn
heterozygous mice [13]. Future studies are required to
clarify the role of the proximal tubule in albumin
homeostasis.
CUBN mutations have previously been described as
causative in Imerslund-Grasbeck Syndrome [14], with
over 20 families have been reported with megaloblastic
anemia and proteinuria associated with truncating bi-al-
lelic CUBN mutations [6, 7]. Our family is the second
described in the literature as having presented with iso-
lated proteinuria as their only phenotypic feature. The
previous family was described by Ovunc et al as having a
novel biallelic 1-bp homozygous deletion in CUBN
resulting in a phenotype of fluctuating proteinuria in
otherwise well individuals [8]. Of note, Boger et al iden-
tified a missense variant (p.I2984V) in CUBN associated
with albuminuria in a genome wide association study
[15]. Further, an association between a CUBN single-nu-
cleotide polymorphisms (SNP) (rs1801239) and ESKD
has been demonstrated in African Americans [16].
Persistent proteinuria is an important marker of
chronic kidney disease and associated with inferior car-
diovascular and renal outcomes [1], and serial dipstick
proteinuria has been identified as an effective strategy to
determine those at risk of rapid renal decline [17]. Most
studies do not differentiate between glomerular or tubu-
lar proteinuria, however heavy proteinuria has been as-
sociated with adverse outcomes in the absence of
complete surety about its glomerular versus tubular
source. Isolated 2+ or 100 mg per dL proteinuria on dip-
stick is associated with a greater risk of end stage kidney
disease than an eGFR < 60 ml/min/1.73 m2 in a 25-year
follow up study of men without identifiable kidney dis-
ease [18]. Current diagnostic workup for proteinuria in-
volves a careful history and examination, multiple urine
samples for confirmation and quantification of protein-
uria and baseline haematology and biochemistry. This is
then followed by renal ultrasound and other increasingly
complex laboratory tests for specific causes of glomer-
ulonephritis or glomerular pathology if indicated [19].
The role of renal biopsy in the investigation of asymp-
tomatic isolated albuminuria is controversial, particularly
in paediatrics, where percutaneous renal biopsy has a re-
ported major complication rate of up to 30% [20–22].
Currently treatment strategies are focussed on glomerular
proteinuria, largely by reducing glomerular filtration pres-
sure with renin-angiotensin system inhibition and blood
pressure control. Although this has been shown to be ef-
fective in reducing decline in kidney function [23], future
directions for therapy should explore targets beyond
glomerular filtration, including the proximal tubule. Previ-
ously, the proximal tubule was thought to be non-perme-
able to albumin. More recent data challenges this concept
suggesting an identifiable role for the proximal tubule in re-
absorption of filtered albumin [24]. The megalin-cubulin
complex is one identified mechanism for proximal tubular
uptake of albumin that is filtered through the glomerular
filtration barrier. The role of this complex has been investi-
gated in knockout animal models [12]. There are, however,
some differences between human and mouse kidney
models. Increase in urinary DBP was observed in megalin-
deficient and cubulin-deficient humans [7, 25], but not in
cubulin-deficient mice [26] that had intact megalin. This in-
dicates that functional megalin is sufficient for normal
tubular reabsorption in mice, but not in humans.
This family, in addition to the one previously described
in the literature provides further evidence for gene-disease
validity association, which will be important in guiding the
interrogation and interpretation of genomic data in renal
patients presenting with proteinuria [27]. We propose that
isolated proteinuria could result from mutations in CUBN
secondary to deficiency of albumin uptake by the proximal
tubule, resulting in a renal limited form of Imerslund-
Grasbeck Syndrome. This may represent a phenocopy of
other isolated proteinuric kidney diseases. Although the
patient in our case also demonstrated thinning of the
GBM on biopsy, we do not believe that this was the cause
of his proteinuria due to the absence of haematuria and
other structural anomalies on light and electron micros-
copy. This family highlights the need to include CUBN in
the genomic diagnostic approach to proteinuria. As the
availability of next-generation-sequencing (NGS) increases
and costs decrease, genomic testing is now being increas-
ingly considered a part of the standard workup of chronic
kidney disease. We suggest genomic testing should be per-
formed in patients with proteinuria with a strong suspi-
cion of genetic disease, antecedent to or concurrent with
renal biopsy depending upon clinical scenario and ur-
gency, particularly where markers of proximal tubular
proteinuria are present [28].
CUBN mutations have been implicated as a hereditary
cause of megaloblastic anaemia and variable proteinuria.
This family is the second described in the literature to
have a monogenic CUBN-mediated cause of isolated
proteinuria, approximating a renal-limited form of Imer-
slund-Brasbeck Syndrome and phenocopying other
forms of isolated proteinuria. Therefore, we describe
how genomic sequencing can successfully identify a sin-
gle gene cause of nephropathy in a clinically relevant
and applicable manner. This report strengthens the
gene-disease validity association for CUBN, with impli-
cations for the practice of diagnostic laboratories. Fur-
thermore, this case supports the argument that genomic
sequencing should be undertaken earlier in the
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diagnostic workup in order to reduce the need for inva-
sive investigations, such as renal biopsy. Future cases
with long term follow up of isolated proteinuria due to
CUBN mutations will help to inform the management
and prognosis of these patients.
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